Form 4: Abeona Therapeutics Executive Sells Shares to Cover Tax Obligations

Brendan M. O'Malley, SVP and General Counsel of Abeona Therapeutics, sold shares to cover tax obligations upon vesting of restricted stock.

Summary

• On June 5, 2024, Brendan M. O'Malley, SVP and General Counsel of Abeona Therapeutics, disposed of 10,951 shares of common stock.
• The shares were surrendered to satisfy tax withholding obligations upon the vesting of restricted stock.
• The transaction was executed at a price of $4.52 per share.
• Following the transaction, O'Malley directly owns 177,675 shares of Abeona Therapeutics.
• The disposition of the withheld shares is exempt pursuant to Rule 16b-3(e).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, which is a normal part of executive compensation. It doesn't necessarily reflect a positive or negative view of the company's future.

Industry Context

This is a routine transaction where company executives sell shares to cover tax obligations related to vesting equity. It is a common practice and doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates